+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Should young age be a contra-indication to breast conservation treatment in Chinese women? Twelve-year experience from a public cancer centre in Hong Kong



Should young age be a contra-indication to breast conservation treatment in Chinese women? Twelve-year experience from a public cancer centre in Hong Kong



Hong Kong Medical Journal 15(2): 94-99



It has been proposed that young women should not be treated by breast conservation treatment because of a higher risk of local recurrences and worse survival. We therefore examined whether breast conservation treatment in young Chinese women yielded inferior clinical outcomes compared to modified radical mastectomy. Retrospective study. Clinical oncology department in a public hospital in Hong Kong. A total of 258 Chinese women with invasive breast cancer, aged below 40 years, and referred between January 1994 and July 2006. A total of 124 (48%) and 134 (52%) patients were treated by breast conservation treatment and modified radical mastectomy, respectively. Mastectomy patients tended to have larger primary tumours (P<0.001) and more nodal involvement (P<0.001). At a median follow-up of 6.5 years, there was no significant difference in the local failure-free survival rate (92% vs 93%, P=0.324) and loco-regional failure-free survival rate (89% vs 88%, P=0.721) in patients having breast conservation treatment and mastectomy. Probably due to their earlier presentation with disease, the former actually had better 6-year distant failure-free survival (88% vs 71%, P=0.002) and overall survival (92% vs 81%, P=0.173) rates. Multivariate analyses showed that both the resection margin status (hazard ratio=2.77, P=0.050) and the presence of peritumoural vascular invasion (hazard ratio=3.01, P=0.038) were independent predictors of local recurrence; the nodal status (hazard ratio=3.91, P<0.001) was the only predictive factor for overall survival. The choice of breast conservation treatment (vs modified radical mastectomy) had no apparent adverse impact on all the clinical outcome parameters analysed. Breast conservation treatment is a reasonable option for many suitably selected young Chinese women.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 055766292

Download citation: RISBibTeXText

PMID: 19342734


Related references

Delayed presentation of symptomatic breast cancers in Hong Kong: experience in a public cancer centre. Hong Kong Medical Journal 16(5): 373-377, 2011

Breast conservation therapy for invasive breast cancer in Hong Kong: factors affecting recurrence and survival in Chinese women. Australian and New Zealand Journal of Surgery 67(2-3): 94-97, 1997

Breast conservation treatment in women with locally advanced breast cancer - experience from a single centre. International Journal of Surgery 4(2): 106-114, 2007

Treatment outcome of craniopharyngioma: 18-Year experience at a Hong Kong regional neurosurgical centre. Surgical Practice 21(2): 76-81, 2017

Nighttime eating and breast cancer among Chinese women in Hong Kong. Breast Cancer Research 19(1): 31, 2017

Breast cancer screening practices among Hong Kong Chinese women. Cancer Nursing 37(1): 59-65, 2015

Relationship between Chinese medicine dietary patterns and the incidence of breast cancer in Chinese women in Hong Kong: a retrospective cross-sectional survey. Chinese Medicine 12: 17, 2017

Supportive care needs in Hong Kong Chinese women confronting advanced breast cancer. Psycho-Oncology 22(5): 1144-1151, 2015

Factors associated with the use of breast and cervical cancer screening services among Chinese women in Hong Kong. Public Health 115(3): 212-217, 2001

Factors related to sexual health in Chinese women with breast cancer in Hong Kong. Asia-Pacific Journal of Clinical Oncology 4(4): 218-226, 2008

Optimizing resource allocation for breast cancer prevention and care among Hong Kong Chinese women. Cancer 118(18): 4394-4403, 2012

Familial risks and estrogen receptor-positive breast cancer in Hong Kong Chinese women. Plos One 10(3): E0120741, 2016

Family beliefs about diet and traditional Chinese medicine for Hong Kong women with breast cancer. Oncology Nursing Forum 30(5): 834-840, 2003

Factors influencing delayed presentation with symptomatic breast cancer in Hong Kong Chinese women. Hong Kong Medical Journal 15(3 Suppl 4): 4-7, 2009

Toxicity of docetaxel plus cyclophosphamide as adjuvant therapy for breast cancer in Chinese patients the Hong Kong experience. Asia-Pacific Journal of Clinical Oncology 5(2): 123-128, 2009